Healthcare provider profile · identity verified

Jonathan J. Kanz, DO

Internal Medicine · ROSEVILLE, CA · NPI 1265510952

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	410	156
Losartan Potassium	Losartan Potassium	317	110
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	308	69
Amlodipine Besylate	Amlodipine Besylate	285	105
Lisinopril	Lisinopril	250	84
Levothyroxine Sodium	Levothyroxine Sodium	245	84
Trazodone Hcl	Trazodone Hcl	183	44
Albuterol Sulfate Hfa	Albuterol Sulfate	165	65
Tamsulosin Hcl	Tamsulosin Hcl	126	45
Pantoprazole Sodium	Pantoprazole Sodium	123	40
Atenolol	Atenolol	121	44
Furosemide	Furosemide	115	55
Famotidine	Famotidine	106	38
Gabapentin	Gabapentin	104	44
Ibuprofen	Ibuprofen	103	40
Metoprolol Succinate	Metoprolol Succinate	101	39
Omeprazole	Omeprazole	97	35
Metoprolol Tartrate	Metoprolol Tartrate	94	34
Simvastatin	Simvastatin	94	33
Nabumetone	Nabumetone	88	36
Metformin Hcl Er	Metformin Hcl	86	37
Fluticasone Propionate	Fluticasone Propionate	83	37
Sertraline Hcl	Sertraline Hcl	81	25
Hydrochlorothiazide	Hydrochlorothiazide	79	31
Meloxicam	Meloxicam	73	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	69	15
Terazosin Hcl	Terazosin Hcl	67	27
Rosuvastatin Calcium	Rosuvastatin Calcium	55	21
Prednisone	Prednisone	54	43
Temazepam	Temazepam	53	13
Alvesco	Ciclesonide	52	22
Alprazolam	Alprazolam	50	13
Cefadroxil	Cefadroxil	47	40
Potassium Chloride	Potassium Chloride	47	19
Allopurinol	Allopurinol	46	20
Montelukast Sodium	Montelukast Sodium	46	20
Alendronate Sodium	Alendronate Sodium	44	17
Jardiance	Empagliflozin	44	21
Pradaxa	Dabigatran Etexilate Mesylate	43	17
Hydrocortisone	Hydrocortisone	40	14
Clopidogrel	Clopidogrel Bisulfate	39	12
Lovastatin	Lovastatin	39	17
Ondansetron Hcl	Ondansetron Hcl	39	19
Quetiapine Fumarate	Quetiapine Fumarate	39	suppressed
Spiriva Respimat	Tiotropium Bromide	39	16
Venlafaxine Hcl Er	Venlafaxine Hcl	38	15
Carvedilol	Carvedilol	37	15
Duloxetine Hcl	Duloxetine Hcl	37	15
Breyna	Budesonide/Formoterol Fumarate	36	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	14
Divalproex Sodium	Divalproex Sodium	35	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	35	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	14
Tramadol Hcl	Tramadol Hcl	35	12
Donepezil Hcl	Donepezil Hcl	33	suppressed
Glipizide	Glipizide	33	17
Hydroxyzine Hcl	Hydroxyzine Hcl	33	12
Azelastine Hcl	Azelastine Hcl	32	16
Propranolol Hcl	Propranolol Hcl	31	12
Lorazepam	Lorazepam	30	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	29	11
Escitalopram Oxalate	Escitalopram Oxalate	28	14
Morphine Sulfate Er	Morphine Sulfate	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	25
Spironolactone	Spironolactone	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	27	suppressed
Ondansetron Odt	Ondansetron	27	12
Bisoprolol Fumarate	Bisoprolol Fumarate	26	12
Fluoxetine Hcl	Fluoxetine Hcl	26	12
Hydralazine Hcl	Hydralazine Hcl	26	13
Buspirone Hcl	Buspirone Hcl	25	suppressed
Fluconazole	Fluconazole	25	suppressed
Nystatin	Nystatin	25	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	21
Warfarin Sodium	Warfarin Sodium	25	11
Midodrine Hcl	Midodrine Hcl	24	suppressed
Mupirocin	Mupirocin	24	18
Trospium Chloride	Trospium Chloride	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	19
Amoxicillin	Amoxicillin	22	15
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	18
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Fluocinonide	Fluocinonide	21	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	suppressed
Metformin Hcl	Metformin Hcl	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	21	suppressed
Betamethasone Valerate	Betamethasone Valerate	20	14
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	20	suppressed
Acyclovir	Acyclovir	19	11
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Glipizide Er	Glipizide	19	suppressed
Baclofen	Baclofen	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Lidocaine	Lidocaine	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Eliquis	Apixaban	16	suppressed
Humulin N	Insulin Nph Human Isophane	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Primidone	Primidone	14	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Finasteride	Finasteride	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clindamycin Hcl	Clindamycin Hcl	11	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	11	suppressed
Entacapone	Entacapone	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ozempic	Semaglutide	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Rivastigmine	Rivastigmine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error